Primary structure of the virus activating protease: from chick embryo Its identity with the blood clotting factor Xa  by Suzuki, Harukazu et al.
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1. INTRODUCTION ther substantiated by complete N-terminal sequence 
match in both chains between the VAP and the chicken 
!vIosr, if not all, of enveloped animal viruses possess (C) FXa isolated from plasma.. A highly specific and cf- 
an envelope glycoprotein, which mediates fusion be- ficient activation of the viral glycoproteins by VAP was 
tween the viral envelope and host cell membrane, hence explained by analogy 10 activation of the natural 
enables the entry of viral gcnome into cytoplasm. There substrate of FXa, the prothrombin, although no fur- 
is now growing evidence that the fusion glycoprotein is ther structural information for either VAP or CFXa 
activated by posttranslational proteolytic cleavage was available, including their primary structure [7], At 
catalyzed by host cell proteases [l-6], We recently the same time, however, if the VAP is actually identical 
isolated an endoprotease designated VAP (virus ac- with FXa, its presence in the extra-vascular fluid is 
tivating protease) from the allantoic fluid of chick em- unexpected, since FX is usually synthesized in liver, and 
bryo [S]. This VAP cleaves the fusion proteins of exists in plasma as a biologically inactive form 
Sendai virus and Newcastle disease virus in paramyx- (zymogen) until blood clotting starts, Under these cir- 
oviridae and influenza virus A of orthomyxoviridae at cumstances, there is clearly a need to unequivocally 
a specific single arginine-containing site, and plays a show whether the VAP is identical with FXa or not, 
key role in the viral spreading in the allantoic sac. The Mere, we have established the identity by determining 
VAP is a serine protease of 55 kDa heterodimer, con- the primary structure of VA%, and show that the 
sisting of the 23 kDa (light) chain with Ca2* binding presence of VAP in the allantoic fluid is a consequence 
capacity and the catalytic 33 kDa (heavy) chain, which of ectopic expression of the FX gene in the chorioallan- 
are linked to each other by a disulfide bond. The N- toic membrane (CAM). 
terminal amino acid sequence of both chains displayed 
a striking homology with those of the activated form of 
bovine FX (BFXa) and human FX (I-IFXa), a member 
2. MATERIALS AND METI-IODS 
of vitamin K dependent serine proteases of prothrom- 2. I I cDNA cloning of the VAP 
bin family. The similarity of VAP to the FXa was fur- Total RNA was extracted from the CAM of 13mday-old chick em. 
bryos by the method of Chomczynski and Sacchi [$I, and poly(A)* 
RNA was isolated by oligo(dT)-Latex [9]. cDNA was made by using 
CoPrespondence address: Y. Nagai, Research Institute for Disease 
a cDNA synthesis kit (Bharmacia) and cloned into the Apt IO. Two 
Mechanism and Control, Nagoya University School of Medicine, 
sets of oligonucleotide mixture with overlapping sequences, 
Nagoya 466, Japan. Fax: (81) (52) 7315844 
5 ’ -GARGARATGAARCARGG-3’ and 5 ’ .ATGAARCARGGNA- 
AYAT-3’ (R, Y and N denote A+G, C+T and A-tG-+C+T, 
respectively), which were d’educed from the N-terminal amino acid se- 
Abbreviations: FX, factor X; FXa, activated form of FX; VAP, virus quence of the light chain of VAP, were used for hybridization selec- 
activating protease; CAM, chorioallantoic membrane tion at 41°C and 37W, respectively. The cDNA inserts of positive 
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3. fWYJLTS 
3.1. iW.dectrl~r clming 0.f VAP 
Wea~rse the allrrnroic fluid frrato which VAP was 
isolnred consists of liquid derived from the CAM and 
2246=nuelrsfide eDNA sequence for VAP, The primary 
structure of VAP was deduced by using the reading 
frame corresponding to rhe previously determined 
amino acid sequence of VAP (ormina acid residues 
41-U and 241-261, underlined in Fig, 1) 17). The 
-51 9’----6Xv ccc WC C$G TO2 fW ccc OX 6CQ teg ecQi% PM cec( 7EC COF( oee A@ *Y 
1 hlG CCC CCC CGC CTG CtG C?C CT0 CtC CTC %C GCG GCG WG CCG GAC Ght CtS CW GCt G&A CGA GCC GTG tTC AtC MB AM GM hGf 
1 HQC Ma QIy A&I LCU LW Leu LIW LIU LIu CYU hfa ALa kU PN Alp GlU LaU At9 Ala Glu Giy Gly Val Pha Ile Lyl LyS OlU 6ar :: 
61 CCC GAC MO TTC 110 GM AGA ACA AAA CGT GCC MC TCT TTT TTA GAA GM ATG AAG CM GCC MT ATT GM AGA GAA fGC AAC GAG GAG LUO 
31 Afr Asp Lye Phe Lw Glu Arg ?hr Lyr Ar(l Glu Cyn Am Glu Glu 60 
161 CGC TGC TCA AAA GM GAG GCA AGA GAA GCC TTT GM GAC MT GAG hAA ACT GAG GM, TTC TGG MT AtC TAC GTh GAT GGC GAC CAG TGC 270 
61 hrg CYO Sot‘ L~C Glu Glu Ala Arp Glu Ala Phe a&u hap ANI G1u Lyr The GIu Glw Phe Trp Asn 110 Tyr Val hop Gly Asp Gin CYO 90 
211 AGC TCA MT CCA TGT CAC TAT GGT GGA CM TGT AM GhT CGA CTT OBT TCC TAC ACT ?GC TCC TGT tTE GAT GGT TAT CAA GGC AA0 MC 260 
91 Oar Sor Am Pro Cyo Wr Tyr G&y Gly Gin Cyr Lys Asp Gly Lw Gly Sar Tyr Thr Cyn Ser Cyr Lau Asp Gly Tyr Gin Gly Lys Am 120 
361 TGT GM TTT GTC ATA CCG MO TAC TGC MA ATA MC AAT GGT GAC TGT GAG CAG TTC TGC AGC ATC AAA Ati AGC GTG ChG AA0 GM GTC 450 
121 Cys Glu Phm VaL Ila Pro Lys Tyr Cys Lyr Xl* Am Am Gly h$p Cya Glu Cln Phr Gym Sor Ilr Lya Lym SW Vd Gln Lyt CIap Val 150 
451 GTG TGT TCC TGT ACA ACT GGG TAT GAG CTG GCh GAA GAT GGC AAA CM TGT CTT TCA AAA GTA MO TAC CCA TGT CGA AAA GTT CTC ATG 540 
151 vd Cys Sax cys Thr SOE Gly Tyr Glu Lau Ala Glu Amp Gly Lys Gin Cya Vnl Ser Lys Val Lys Tyr Pro Cys Gly Lyo Val Lw Her. 180 
541 lvIA AGA ATT A&A AGC TCT GTC ATC TTA CCC ACT MT ACT AAT ACC MT GCA ACT ACT GAT CMI CAT OTC CCC TCC ACG MT CGA TCA ATT 630 
161 Lys Arg Ila Lya Arg Ser Val 110 Lau Pro Thr Am Ser Aan Thr Am Ale Thr Se!: Asp Gin Aap Val Pro SOE Thr Am Gly Ssr 110 210 
631 CTG GAG GAG GTC TTT ACT ACT ACC ACA QAA AGC CCA ACT CCC CCT CCT CGC AAC GGA TCG ACT ATC ACA OAT CCA AAT GTC GAT ACC AGG 720 
211 Leu Glu Glu Val Pho Thr Thr Thr Thr Olu Sdr Pro Th: Pro Pro Pro Arg Aan GLy Ssr See Ile Thr Asp Pro Asn Vs). Asp Thr Arq 240 
721 ATA GTA GGT Go0 CAT GAG TGT CGT CCT GGT GM TGC CCA TGG CAG CCC GTC CTG ATA AAT GAG AAG GCG GAA GAG TTT TGT GGC CGA ACT 810 
Lys Gly Glu Glu Pha Cya Gly Gly Thr 270 
811 ATA CTG AAT CAA CAT TTC ATC CTT ACT GCT GCT CAT TGC ATA AAC CAA TCC AM GAG ATC AAA GTT GTT GTT GGT GAA GTG CAT AGA GAA 900 
271 Ile Leu Aen Glu Asp Phs Ila Leu Thr Ala Ala His Cya Ile Am ~ln Ser Lya Glu 11s Lys Val V&l Val Gly Glu Vsl Asp Arg Glu 300 
901 RAG GM CM CAT XT GAA ACA ACA CAT ACT GCA GAA RAA ATA TTT OTT CAC TCT AAG TAC ATC WC GAG ACT TAT GAT AAT GAC ATA GCC 990 
301 Lyo Glu Glu Hi8 Ser Glu Thr The His Thr Ala 011.1 Lys Ile Phc Val His ser Lys Tyr Ile Ala Glu Thr Tyr Asp Asn Asp 110 Ala 330 
991 CTC ATA RAG CTG AAG GAA CCC ATA CAG TTT TCC GAG TAT GTT GTC CCA WA TGC CTC CCA CAA GCA GAC TTT GCT AAT GAA GTG CTG ATG 1000 
331 Lnu 11s Lye Leu Lya Glu Pro Ila Gln Pho SW Glu l'yr Val Val Pro Alo Cys Leu Pro Gin Ala Asp Pho Ala Am Glu Val Leu Mqt 360 
1061 AAC CAA WC TCT GGG ATG GTT ACT GGC TTT GGG CGT GRB TTT GM GCT GGA Cc% CTT TCC AAA AGA CTG AAA GTG CTC GAI\ GTC CCC TAT 1170 
361 Am Gln Lya Ser Gly Mat Vnl Ser Gly Phe Gly Arg Glu Phe Glu Ala Cly Aeg Lau Sor Lys Arg Leu Lys Val Leu Glu Val Pro Tyr 390 
1171 GTT GAT AGG AGC ACT TGC AA6 CAG XC ACT ABC TTT GCA ATA ACA GAA AAC ATG TTC TGT GCT GGT TAT GAA ACA GAG CAA AA0 GAT GCT 12GO 
391 Val Asp Arg Ser Thr Cys Lyo Gin Ser The Aan Phe Ala Ile Thr Glu Am Met Phe Cys Ala Gly Tyr Glu Thr Glu Gin Lya Asp Ala 420 
1261 TOT CAA GGA GAC AGT GGA GGC CCC CAT GTA ACC AGA TAT AAG GAT ACT TAC TTT GTT ACT GGA ATT GTT AGC TGG GGA GAA GGA TGT GCA 1350 
421 Cys Gin Gly Aop Sar Gly Gly Pro His Val Thr Arg Tyr Lys AYP Thr Tyr Phe Val Thr Gly Ile Val Ser Trp Gly Glu Gly Cys Ala 450 
1351 AGO AAG GGC AAA TAC GGT GTA TAT ACC RAG CTG TCC AGA TTC TTA COT TGG GTA AGG ACA GTC ATG AGG CAA AAG TAG TAG TGG CGT GGC 1440 
451 Arg Lys Gly Lys Tyr Gly Vel Tyr Thr Lys Leu Ser Arg Phe Leu Arg Trp Val Arg The Vel Mot Arg Gin Lys 415 
1441 TCT 
1531 TTG 
1621 GOT 
1711 AGT 
1801 CCA 
1891 GAA 
1981 ACT 
2071 TTC 
2161 TTC 
CBA ACC TCC CAT TAG GAA 
AAA GCT GGT TTC T'I'G AAG 
GTT TTG AGT TTG TAC AGT 
OTC ATT CTG OTT CCT GTC 
OTC CTC CTA CTG CA6 CCC 
GGG AGA AGG GAA GCT TCC 
TAA GTC ACA GCA CCT RRB 
AGA ABA AX% TAA CAT GTA 
CAG GTG GTA CCG TAA GAT 
ACA 
TTA 
AA0 
TGT 
ACT 
TCG 
TM 
TOT 
GCA 
AGG TGC AGT TTC TCT AAT GGA AAT 
TGG TGC TGC TTC TOT TTT CTT TCT 
GGG CTT TCC GCC AAA CAA AGT GCC 
GCC crux ~Tt-3 ATT CCA CCA GAG GCT 
CAC TCA GTA GGG ACT TTG TTC CCA 
GCC AAA GCT GAG ACA CAA GTA AGT 
AGT CTT GTG TTG CTT TAT ATG GTT 
TCA CTG TTT CCT GTA TTA TAT TCT 
TTA TCA GTG TA-e--3' 
GTT TTT TAT TTG TAT TTT TTR CCC ACA TCT GCT AAA CTT GTT 1530 
TTT ATT TTC TTG ACT TTA AGC ATG TAT ATG TGG TCT GCT GGT 1620 
TGC TCA TTG GTG TCT TCT GA'? TGC TTG ACT GGT TAT TTG CAT 1710 
CCT GGA CAT AAC ATG ATG GAA GTG GGA AGC CCA CGA CTT CAG 1600 
CTG GAG CTT TTT AGC TTC TAC CTC TGG CTG TCC TTG G&A GAT 1890 
ATT CAG TGT GTT GCT AAA CM CCA COT TCC ACA AAA CTT CCC 1980 
GTA CTT CAC TCT AGT TTA ATT TGA ACA CTT ATT TTC TGC TCC 2070 
GGA TTG TGC ATG FCT GAG AAT CGG TCi: TTTTE TGT GTG TAG TTG 2160 
2195 
Fig. 1. Nucleotide sequence of cloned CDNA encoding the virus activating proteasc (VAP) precursor. The predicted amino acid sequence is shown 
below the nucleotide sequence. The two underlines indicate the amino acid sequences previously determined [7]. The nucleotide sequence was 
obtained from the clone pCl-lP21 because it was the longest one obtained. 
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Cr~n~~~ci~~~~ inltienlen she WBSI ~~~~~~~d C%) the chains r\nd prexervatien of pairl~d brrmic amino aeld 
mrrhiatjlnt: cc&n compiased sf nu~l~~tl~~~ residues raaldurs far praCreiyCic ~r~~~~~in$ ~uggett rrrengl-y Chrr 
1-3, beeauxc the? ~~~k~~~~i~ tr~~~~~ti~~ initizttion site: VAFI undergoes pr~~~~$in$ ~n~l~~~u~ CQ that BP BFX 
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t426-1428, Thus, VAP cenoistlc ef475 &mina trcida nnd such as Altt4B, Ser.30 land AM I, and tka mkcr by w 
its ealeul~ted mnlccular weight io 93 139. The seeand protcrrsc elcaving Arg.40 an Chc cnrboxy tmd of 
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revealed & high hsmelogy with BFX or WFX. The molecule is converted to the @nnymaCie~lly active VAQ 
mlignmcnt in Fig. 2 indieatcs that VAP emoirsts of the corresponding to FXa by eleavage between lug-240 
prepre leader peptide (amine, acid residues i-40), the and k-241 to remove the activation peptide. The 
light chain (41-IgS), the activation pcpridc (186-240) caleulatcd molecular weight of pVAP, VRP and eetiva- 
and the heavy chnin (241-475). Scqucnee information Cion peptide are npprsxirnatcly 49OOU,43000 and 6000, 
already available fcs the N-Ccrmini of light and heavy rqxctively, These values arc in good agreement with 
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Fig. 2. Alignment of the amino acid sequence of the preprb form of VAP (top), BFX (middle) and HFX (bottom). Identical amino acids at the 
same position are boxed, Gaps have been introduced to maximire the homology. The two solid arrows are possible processing sites and the open 
arrow is the cleavage site for wctivation. The solid arrowheads and solid circle indicate presumable y-carboxylated residues and a &hydroxylated 
residue, respectively. All cysteine: residues conserved in the three sequences are indicated by open arrowheads. The catalytic triads are in dotted 
boxes. The sequence data for BFX and MFX are from [21-241. 
rhe molecular mass c~timatcd by 4oJium dodceyl Li vor 
rulftttlrc pol~aer~~arn~de glel ~l~~tr~ph~r~$~$ (70 kDa, 
55 kDa and I II kDn, rcupcerivcly) [7], nskumin$. that the 
potential N.&eo,sylarion &es wref actually urililrrd at d 
rcridueo 196, 307, 228 and 28% ,. ‘, 
Pig, 2 further shows that evsentinlly all functionnl Wgin- 
and structural domains and residues charncterMic of .’ ” ,
BFX or NFX are csnrcrued in VAP. In the light chain 
.,I ,,*,,: 
of BFX and HFX, the: clevcn glutamic acid residues in 
the Wterminal region are known to be posrtmnsln- 
tionally converted to +arboxyglutamic acids (Ola) in 
a vitamin K-dependent process, and serve ~1s Ca;“” bin- 
ding sites [ 161. VAP also requires Ca’* for virus aerive- 
tion and its N-terminal three glutamic acid residues 
were already suggested to be v_carboxylated [t]. The 
strict conservation of those three nnd the additional 
eight glutamic acid residues suggests that they are in- 
deed ymcarboxylated and play a crucial role in Ca’+ bin- 
ding. After this Gla domain, two potential growth 
factor domains exist, The cysteine residues important 
for this domain formation are well conserved at posi- 
tions 90.95, 101, 110, 112,121, 129, 136,140,152, 154, 
167, and cysteineql75 is likely involved in the interchain 
bond together with cysteine-348 in the heavy chain, The 
asparcic amino acid conserved at position 103 could be 
,&hydroxylatcd [15], In the heavy chain, the three prin- 
cipal amino acids (His-282, Asp-328 and Ser-425) par- Fig, 3. NOI hybridization nsalysir of chick poly(A)* RNA from 
ticipating in catalysis (the catalytic triad) are completely 
CAM, cnlbryonic liver nnd FLdUII Ilvcr. The itmallnl of Cdl pdYtA)* 
RNA used wns 5 /r&t, Autoradioprephy WPS pcrhrmcd nr -WC for 
preserved. In addition, all predicted amino acid Sr! h with on intcnsifyiqt screen. 
residues which effect substrate binding of FXa [17], 
residues 266, 325, 372, 420, 422, 447, 448 and 450 are 
strictly conserved in the three sequences. Furthermore, was approximarely 2.5 kb and therefore well-matched 
the cysteine residues crucial for domain formation of to the cDNA size. 
the catalytic heavy chain are also completely conserved 
at positions 247, 252, 267, 283, 348, 396, 410, 421 and 
449. 
4. DISCUSSION 
These results serongt, ;uggest that VAF is identical In this paper, we cloned and sequenced a cDNA 
with CFXa and pVAP corresponding to CFX. Further specific for the tnRNA encoding VAP of chick embryo, 
substantiating this, a cDNA clone with the identical and demonstrated that YAP is, by all molecular 
deduced amino acid sequence was obtained by using the biological criteria employed, identical with FXa. Both 
same oligonucleotide probes from aduh fowl liver the successful isolation of cDNA from the CAM and 
where FX is known to be constitutively synthesized the blot hybridization analysis of poly(A)+ RNA giving 
(data not shown). a clear, specific signal for the CAM indicate an ectopic 
expression of FX in this organ. In addition, by specific 
3.3. Eqmssion of VAP mRNA in both the CAM and immunofluorescent staining, we detected the FX 
the liver of chick embryo molecule in the endodermal cell layer of the CAM, 
In higher organisms, FX is synthesized inthe liver as which is in direct contact with the allantoic fluid 
one of the zymogens in the blood clotting cascade. To (manuscript in preparation). Therefore, it is a 
further confirm the identity between VAP and CFXa, reasonable assumption that FX is synthesized in the en- 
expression of VAP-specific mRNA in the liver was in- doderm of the CAM, secreted into the allantoic fluid 
vestigated by blot hybridization analysis of poly(A)” and converted to the active FXa. In mammals, the pro- 
RNA. A 3 ‘-non-coding region of VAP cDNA was used cessing of FX to FXa is done by factor IXa or factor 
as a specific probe, and hybridization was performed VIIa at a middle phase of the blood clotting cascade 
under the strict condition as described in section 2, A [IB]. The enzymes responsible for this conversion in the 
discrete signal was observed at exactly the same posi- allantoic cavity are not known. Also to, be elucidated 
tion in both the embryonic and the adult liver as well are the physiological roles beside clotting, which the 
as in CAM (Fig. 3) The estimated size of the RNAs FX/FXa may play in chick embryogenesis. In this 
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